Inhibiting Dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma

被引：0
|
作者：
Heath, D. J. [1 ]
Chantry, A. D. [1 ]
Buckle, C. [1 ]
Coulton, L. [1 ]
Shaughnessy, J. D., Jr. [2 ]
Evans, H. [1 ]
Stover, D. R. [3 ]
Vanderkerken, K. [4 ]
Croucher, P. I. [1 ]
机构：
[1] Univ Sheffield, Acad Unit Bone Biol, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[3] Biomed Res Inc, Novartis Inst, Cambridge, MA USA
[4] Vrije Univ Brussels, Dept Haematol & Immunol, Brussels, Belgium
来源：
CALCIFIED TISSUE INTERNATIONAL | 2008年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] Inhibiting dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma
    Heath, Debby
    Chantry, Andrew
    Buckle, Clive
    Coulton, Les
    Shaughnessy, John, Jr.
    Evans, Holly
    Stover, David
    Vanderkerken, Karin
    Croucher, Peter
    CANCER TREATMENT REVIEWS, 2008, 34 : S52 - S52
  • [2] Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
    Heath, Deborah J.
    Chantry, Andrew D.
    Buckle, Clive H.
    Coulton, Les
    Shaughnessy, John D., Jr.
    Evans, Holly R.
    Snowden, John A.
    Stover, David R.
    Vanderkerken, Karin
    Croucher, Peter I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (03) : 425 - 436
  • [3] Dickkopf-1 (Dkk-1) is involved in the development of breast cancer osteolytic lesions
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S27 - S27
  • [4] Platelets Contribute to Circulating Levels of Dickkopf-1 (Dkk-1): Clinical Implications in Multiple Myeloma.
    Voorzanger-Rousselot, N.
    Goehrig, D.
    Clezardin, P.
    Facon, T.
    Garnero, P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S297 - S297
  • [5] Effects of Dickkopf-1 (DKK-1) on Prostate Cancer Growth and Bone Metastasis
    Yuan, Shiyu
    Hoggard, Nathan K.
    Kantake, Noriko
    Hildreth, Blake E.
    Rosol, Thomas J.
    CELLS, 2023, 12 (23)
  • [6] Serum dickkopf-1 (DKK-1) in breast cancer patients with bone metastases
    Journe, Fabrice
    Kheddoumi, Naima
    Doriath, Valerie
    IdBoufker, Hichamel
    Durbecq, Virginie
    Larismont, Denis
    Voorzanger-Rousselot, Nathalie
    Gamero, Patrick
    Body, Jean-Jacques
    ACTA CLINICA BELGICA, 2008, 63 (02): : 127 - 127
  • [7] Bone morphogen dickkopf-1 (DKK-1) is a prognostic biomarker for progression of hip osteoarthritis.
    Lane, N. E.
    deLeon, P.
    Nevitt, M. C.
    Lui, L.
    Corr, M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S666 - S666
  • [8] Serum levels of Dickkopf-1 (Dkk-1) are increased in women with breast cancer and bone metastases
    Voorzanger-Rousselot, N.
    Goehrig, D.
    Clezardin, P.
    Garnero, P.
    CANCER TREATMENT REVIEWS, 2006, 32 : S38 - S38
  • [9] Epigenetic silencing of the WNT antagonist dickkopf-1(DKK1) in multiple myeloma
    Kocemba, K. A.
    Groen, R. W.
    Kersten, M. J.
    Bloem, A. C.
    Lokhorst, H. M.
    Spaargaren, M.
    Pals, S. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 117 - 117
  • [10] Serum dickkopf-1 (DKK-1) is unrelated to radiographic severity in ankylosing spondylitis
    O'Shea, Finbar D.
    Chiu, Basil
    Haroon, Nigil
    Inman, Robert D.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S349 - S350
12345